Leyden Laboratories
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
€40MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops broadly protective antibody-based nasal sprays to prevent infection by influenza and other respiratory viruses
Develops a hydrogel system to treat uterine health conditions and prevent scarring
Pitching ClavystBio? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room